» Articles » PMID: 2664901

Pronounced Reduction of in Vivo Prostacyclin Synthesis in Humans by Acetaminophen (paracetamol)

Overview
Journal Prostaglandins
Date 1989 Mar 1
PMID 2664901
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of a single dose of 500 mg acetaminophen (paracetamol) on the in vivo synthesis of prostacyclin was studied in healthy volunteers by measurements of the urinary excretion of 2,3-dinor-6-keto-PGF1 alpha. Acetaminophen caused a marked reduction of prostacyclin synthesis for 6-8 hours without any obvious effect on the thromboxane synthesis. Thus, acetaminophen may at least theoretically be disadvantageous for patients suffering from diseases where prostacyclin mediated vascular defence mechanisms are activated, like myocardial infarction, deep vein thrombosis and following surgery.

Citing Articles

Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews.

Mitra S, de Boode W, Weisz D, Shah P Cochrane Database Syst Rev. 2023; 4:CD013588.

PMID: 37039501 PMC: 10091483. DOI: 10.1002/14651858.CD013588.pub2.


Dual medication therapy (acetaminophen and ibuprofen) for the management of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis.

Shah S, Makker K, Zhang M, Harnett S, Aziz K, Hudak M J Perinatol. 2022; 42(12):1654-1661.

PMID: 36008521 DOI: 10.1038/s41372-022-01500-8.


Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis.

Mitra S, Gardner C, MacLellan A, Disher T, Styranko D, Campbell-Yeo M Cochrane Database Syst Rev. 2022; 4:CD013846.

PMID: 35363893 PMC: 8974932. DOI: 10.1002/14651858.CD013846.pub2.


Longitudinal Study of Analgesic Use and Risk of Incident Persistent Tinnitus.

Curhan S, Glicksman J, Wang M, Eavey R, Curhan G J Gen Intern Med. 2022; 37(14):3653-3662.

PMID: 35132561 PMC: 9585140. DOI: 10.1007/s11606-021-07349-5.


Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal.

Pandolfi S, Chirumbolo S, Ricevuti G, Valdenassi L, Bjorklund G, Lysiuk R Basic Clin Pharmacol Toxicol. 2021; 130(2):225-239.

PMID: 34811895 PMC: 9011697. DOI: 10.1111/bcpt.13690.